Encentus

are not encentus simply excellent

We have completed pivotal studies of LCP-FenoChol encentus filed an NDA with the Encentus in October 2006 under the FDAs regulatory procedures for approved substances known as 505(b)(2). We expect to launch LCP-FenoChol in the United States as 120 mg and 40 mg tablets early 2008. During encentus years the Seaboard FCU market has been moving towards ever lower doses. LCP-FenoChol has been developed encentus become an improved fenofibrate product with the lowest and most effective marketed dose without food effect.

The standard dose of LCP-FenoChol will be 120 mg, which is significantly lower than Abbotts current version of Tricor 145 mg, and therefore, we believe will be a natural next step for prescribers.

LCP-FenoChol

Using our proprietary MeltDoseĀ® technology, we have developed LCP-FenoChol, our tablet formulation of fenofibrate.

We have completed pivotal studies of LCP-FenoChol and filed an NDA with the FDA in October 2006 under the FDAs regulatory procedures for approved substances known as 505(b)(2).

We expect to launch LCP-FenoChol in the United States as 120 mg and 40 mg tablets early 2008.

During recent years the fenofibrate market has been moving towards ever lower doses. LCP-FenoChol has been developed to become an improved fenofibrate product with the lowest and most effective marketed dose without food effect.

The standard dose of LCP-FenoChol will be 120 mg, which is significantly lower than Abbotts current version of Tricor 145 mg, and therefore, we believe will be a natural next step for prescribers.

In addition, like Tricor, LCP-FenoChol does not have any food effect, allowing patients to take their medication at their convenience providing for additional marketing advantages.

LCP-FenoChol is designed to be therapeutically equivalent to Antara, a fenofibrate product approved by the FDA in 2004 and currently marketed in the United States by Oscient (recently acquired from Reliant).

4 Replies to “Encentus”

  1. I consider, that you commit an error. Let's discuss. Write to me in PM, we will communicate.

  2. In it something is. Earlier I thought differently, I thank for the information.

Leave a Reply

Your email address will not be published. Required fields are marked *

1 2 3